MTNB
Matinas Biopharma Holdings (MTNB)
$23
About Matinas Biopharma Holdings (MTNB)
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.
Details
Daily high
$3.29
Daily low
$3.02
Price at open
$3.04
52 Week High
$44.50
52 Week Low
$2.95
Market cap
16.2M
Dividend yield
0.00%
Volume
52,330
Avg. volume
38,009
P/E ratio
-.63
Matinas Biopharma Holdings News
Details
Daily high
$3.29
Daily low
$3.02
Price at open
$3.04
52 Week High
$44.50
52 Week Low
$2.95
Market cap
16.2M
Dividend yield
0.00%
Volume
52,330
Avg. volume
38,009
P/E ratio
-.63